Introduction

47
Nonsteroidal anti-inflammatory drugs (NSAIDs) are a heterogeneous class that non-48 selective/selective inhibitors for cyclooxygenase (at least two isoforms: COX1 and COX1). Commonly 49 prescribed for their NSAIDs (such as: aspirin, paracetamol, ibuprofen, naproxen, and diclofenac) are 50 extensively used for the relief of pain, fever and treatment of inflammatory conditions [1, 2] . The 51 common mechanism of these drugs is the ability to decrease prostaglandin synthesis by inhibiting COX
52
(COX also known as prostaglandin-endoperoxide synthase). NSAIDs vary in their relative inhibitory 53 effects on COX-1 and COX-2. There are worried that the COX-2 inhibitors may increase 54 cardiovascular diseases [3] . The overdose of NSAIDs is associated with an increased toxicity. Also, 55 this toxicity can lead to multiple complications, and may be result in death.
56
N-acetyl-p-aminophenol (APAP), also known as paracetamol or acetaminophen, is a non-57 prescription drug used as an analgesic, and anti-pyretic drug globally, considered safe and effective at 58 therapeutic doses. APAP toxicity is one of the main causes of poisoning world-wide. Several studies 59 reported that excessive use or overdose of APAP can damage several organs (especially the liver: 60 represents the site of formation of the toxic metabolites, and the kidney: represents the site of its 61 clearance) and even death [4, 5] . Its toxicity is mediated by the activity of its reactive metabolite (N-62 acetyl-p-benzoquinoneimine, NAPQI), that generated via cytochrome P450 in liver. NAPQI is 63 detoxified by the antioxidant effects of intracellular glutathione (GSH). Thus, an overdose of APAP 64 cause depletion of cellular GSH. Therefore, it led to a reduced GSH capacity to detoxify NAPQI.
65
Elevation of NAPQI mediates oxidative damage. This subsequently enhances cellular injuries and 66 organ dysfunction [6] . Other studies reported that acute renal damage/failure can occur by overdose 67 APAP even in the absence of liver damage/failure [6, 7] .
68
Several studies reported that APAP exerts acute and/or chronic hepato-toxic, nephro-toxic 69 effects, gastrointestinal complications and hyperplasia of splenic tissue as well as cardio-toxicity Rats were divided into four groups (n = 6), i.e., Group I (healthy control group): rats received orally The results were expressed as mean values with their standard errors (SE). Data was analyzed using 151 ANOVA, and the differences between groups were determined by Tukey's multiple comparison test 152 using Graph Pad Prism. Differences at P<0.05 were considered statistically significant.
153
Results
155
In Fig 1, the body weight gain and relative kidney weight were significantly decreased and 156 increased (p < 0.05-0.001), respectively, in APAP-intoxicated group in contrast to the control group.
157
This was not accompanied by significant change in spleen and heart relative weights (p>0.05). Oral 158 treatment of nHEAFL completely modulated the decrease in in the body weight loss (p>0.05; compared 159 to the healthy control animals), and partially alleviated the increase in relative kidney weight 160 (p<0.05/p<0.001; compared to the healthy/APAP intoxicated control animals, respectively). 
169
intoxicated group compared with control rats (Fig 2) . In addition, granulocytes and agranulocytes were 170 a slight but not significant increase (p>0.05) in APAP-intoxicated group compared with control rats.
171
All these hematological parameters did not significantly change (p>0.05) in APAP treated with 172 nHEAFL compared with the healthy/ APAP-intoxicated control rats (Fig 2) . All the above parameters measured in the present study were not significantly altered (p>0.05) 209 in healthy-treated rats that received nHEAFL compared with the healthy control rats (Figs 1-4) .
210
Furthermore, the mortality rates in all groups that received nHEAFL were zero during the period of the 211 study. Subsequently, no deleterious effects were detected for the dose of nHEAFL used in this study. clearance of ROS and lipid peroxidation, and the stability of the function during organs injury [19, 20] . Recently, bioactive phenolics such as brevifolin carboxylic acid, ellagic acid, gallic acid and 263 methyl gallate were identified from the extract of AFL [16, 17] , and may be responsible for its radical 264 scavenging activity [38] .
265
Our previous studies have indicated that nHEAFL (500 mg/kg,p.o, for 7 to 21 days) plays an 266 important role in improving GSH status and total anti-oxidant capacity in intoxicated rats with APAP 267 [2, 20] . In this study, the high level of GSH in response to nHEAFL may result from increased activity 268 of cellular anti-oxidant enzymes and decreased cellular lipid peroxidation.
269
Higher activity in nHEAFL may be due to presence of α-tocopherol (an isoform of vitamin E 270 and as an anti-oxidant agent), which has a powerful anti-oxidant activity in detoxifying free radicals, anti-oxidant as well as anticancer activities [2, 45] . Taking this fact with gained results we could suggest 296 that the amount of exogenous polyphenolic diets increases, endogenous anti-oxidant defense system 13 297 increase as well. Therefore, the medicinal anti-oxidant therapeutic will offers a promising way to 298 prevent and/or treat the diseases induced by the excessive exposure to oxidative stress (ROS/NOS).
299
Finally, our study demonstrated that nHEAFL has important anti-oxidant effects as ability to 300 scavenge ROS, inhibit lipid peroxidation as well as increase of anti-oxidant defense system in kidney, 301 spleen, and heart tissue organs; which was attributed to presence of mainly α-tocopherol, terpenoidal 302 and steroids compounds. 
